CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples
Genes · 2025
DOI: 10.3390/genes16101233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Ermanno Nardon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences (DSM), University of Trieste, 34149 Trieste, Italy. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Lyme Disease, Borrelia burgdorferi Group. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DOTT, Associazione Lyme Italia e coinfezioni.
Abstract (Originalsprache)
Background/Objectives: Lyme disease diagnosis remains challenging due to the limitations of current methods. While PCR-based assays are widely used, their sensitivity can be affected by sample type and the inhibition of host DNA. This study aimed to evaluate the feasibility and sensitivity of a CRISPR/Cas12-based detection system for Borrelia burgdorferi sensu lato, comparing its performance with real-time PCR.
Methods
DNA from three Borrelia genospecies (B. burgdorferi, B. garinii, and B. afzelii) was amplified targeting the OspA gene. Detection was performed using a Cas12/crRNA system with a fluorescent ssDNA reporter. Sensitivity assays were conducted on serial dilutions of Borrelia DNA, with and without human genomic DNA, and results were compared with qPCR.
Results
Direct detection of Borrelia DNA without amplification was not feasible. However, when combined with PCR, the Cas12/crRNA system reliably detected as few as 5 genome copies per reaction. End-point PCR extended to 60 cycles improved detection robustness for B. garinii and B. afzelii, although sensitivity decreased in the presence of human genomic DNA.
Conclusions
The Cas12/crRNA-based system offers a sensitive and accessible alternative to qPCR, especially in settings lacking real-time PCR instrumentation. Future developments may include integration with isothermal amplification and microfluidic platforms to enhance direct detection capabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences (DSM), University of Trieste, 34149 Trieste, Italy.
- AB Analitica S.r.l., 35127 Padova, Italy.
ORCID-Profile: Eros Azzalini, Diego Boscarino, Serena Bonin
Förderung
- DOTT
- Associazione Lyme Italia e coinfezioni
Zitieren
APA
Nardon, E., Azzalini, E., Paladin, D., Boscarino, D., & Bonin, S. (2025). CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples. Genes. https://doi.org/10.3390/genes16101233
Vancouver
Nardon E, Azzalini E, Paladin D, Boscarino D, Bonin S. CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples. Genes. 2025. doi:10.3390/genes16101233
BibTeX
@article{Nardon2025,
author = {Nardon, Ermanno and Azzalini, Eros and Paladin, Dino and Boscarino, Diego and Bonin, Serena},
title = {CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16101233}
}
EUVIMED